Experts writing in the Journal of the Royal Society of Medicine disagree with the conclusion that PIP breast implants do not show any evidence of significant risk to human health. This was the decision reported in June 2012 by the panel appointed to investigate the PIP breast implant scandal chaired by NHS medical director Sir Bruce Keogh. Disputing this the authors point to evidence showing that the PIP implants were found to contain a higher proportion of a group of small-sized molecules than the norm, including one referred to as D4 which has been identified as an endocrine disrupting chemical(EDC). In low doses, EDCs are known to cause damage to a developing foetus.
Co-author Andre Menache, director of consumer protection organisation Antidote Europe, says: “Considering these known risks and the fact that most women receiving breast implants were of reproductive age, we would expect the MHRA and the Department of Health to fulfil its duty of care and thoroughly investigate these risks as well as provide full information to patients.” more info;
